U.S. Markets open in 30 hrs, 4 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 03:55 PM EDT | 0.45 | |
|---|---|---|
| Day High 03:55 PM EDT | 0.45 |
|
| Range | 0.00 | |
| Volume | 100 | |
| 30-Day Avg. Vol. | — |
|
| Difference | — | |
| Market Cap. | 13.14 M | |
| Change | 2.92 M | |
| Shares Out. | 19.11 M | |
| Percent Traded | 0.00% | |
| Revenue (LFY) | — | |
| Earnings (TTM) | — | |
| Next Earnings | - |
|
| EPS (TTM) | -1.02 |
| 52-Wk Low 3/18/08 | 0.21 | |
|---|---|---|
| 52-Wk High 5/21/08 | 1.01 |
|
| Range | 0.80 | |
| Prev. Close 9/4/08 | 0.35 | |
| Today's Open | 0.45 | |
| Change | 28.57% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | — | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Synovics Pharmaceuticals (formerly Bionutrics) is looking for a new edge. The company is focused on marketing over-the-counter pharmaceuticals and bringing new generic products to market in the US. Synovics ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — — | — — |
—
—
|
| Last Quarter | — — | — — |
—
—
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
